🧬 Gastric Pentadecapeptide • Healing

BPC-157

Synthetic 15-amino acid peptide derived from human gastric juice with remarkable tissue-healing, anti-inflammatory, and cytoprotective properties across multiple organ systems.

Length 15 aa MW ~1419.5 Da CAS 137525-51-0

⚡ Executive Summary

BPC-157 (Body Protection Compound-157) is a research peptide known for accelerating repair of muscles, tendons, bones, and gut ulcers. It works by promoting angiogenesis, boosting growth factors, and reducing inflammation. In animal studies, it shows remarkable healing without significant side effects. Not FDA-approved — remains experimental and is banned in sports by WADA.

Jump to section

01 Overview 02 Properties 03 Mechanism 04 Benefits 05 Dosage 06 vs TB-500 📋

Overview

🧬 What is BPC-157?

BPC-157 is a synthetic 15-amino acid peptide first derived from a protective protein found in human gastric juice.

It acts as a broad-spectrum cytoprotective and pro-angiogenic agent, orchestrating multiple healing pathways simultaneously.

🎯 Key Actions

• 🩸 Angiogenesis — promotes new blood vessel growth
• 📈 Growth factors — upregulates VEGF, ERK, AKT
• 🔥 Anti-inflammatory — reduces IL-6, TNF-α, COX-2

⚠️

Research only: BPC-157 is not FDA-approved and is banned in competitive sports by WADA. All evidence is from animal studies — human clinical trials are lacking.

🔬

Entity Properties

Aliases	BPC-157, Body Protection Compound-157, PL-14736, Bepecin
Sequence	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Length	15 amino acids
Molecular Weight	~1419.5 Da
CAS Number	137525-51-0
Family	Gastric pentadecapeptide, cytoprotective peptide
Diluent(s)	Bacteriostatic water (0.9% benzyl alcohol) or sterile saline
Concentration	5 mg + 2 mL = ~2.5 mg/mL; 10 mg + 2 mL = ~5 mg/mL
Storage (dry)	2–8°C refrigerated; stable for months
Storage (solution)	2–8°C; use within 4–6 weeks; avoid freeze-thaw

⚙️

Mechanism of Action

🧠 How does BPC-157 work?

BPC-157 works by activating multiple healing pathways simultaneously — a “broad-spectrum” repair peptide. It promotes blood vessel formation (VEGF↑), triggers cell survival pathways (ERK1/2, AKT), and boosts growth hormone receptor expression in tendon cells.

It also increases nitric oxide synthase (NOS) activity for improved blood flow and quenches inflammation by lowering IL-6, TNF-α, COX-2, and myeloperoxidase.

🩸 Angiogenesis

Increases VEGF → new blood vessels → enhanced nutrient delivery to injured tissues

📈 Growth Signals

Upregulates ERK1/2, AKT, and growth hormone receptor → cell proliferation & migration

🔥 Anti-Inflammatory

Reduces IL-6, TNF-α, COX-2, myeloperoxidase → less swelling and pain

💡

Multi-modal action: BPC-157 protects cells from stress, stimulates growth factors, opens blood vessels, and dials down inflammation — explaining why it benefits diverse injury types from tendons to gut ulcers.

✨

Research Benefits

🐭 Preclinical Findings (Animal Studies)

🦴

Tendon & Ligament

Accelerated Achilles tendon repair; stronger fiber alignment; restored joint stability in ligament injuries

💪

Muscle Regeneration

Faster muscle fiber regeneration; larger fibers, less atrophy; quicker return of strength

🦴

Bone & Joint

Supported bone healing; as effective as bone grafts in non-union fracture models

🫁

GI Protection

Potent anti-ulcer effects; faster ulcer healing; protection against NSAID-induced gut injury

🧠

Neuroprotection

Reduced brain damage in stroke/trauma models; modulates serotonin/dopamine pathways

✅

Safety Profile

No significant toxicity at wide dose ranges; no organ damage in animal studies

⚠️

Important: All benefits are from animal studies. Human outcomes may differ. No large-scale clinical trials have been completed. A Phase 1 trial is testing oral BPC-157 for ulcerative colitis.

💉

Dosage & Administration

📘

Research use only. No official human dose guidelines exist. The following is educational based on animal data and common research protocols.

📊 Dosing Reference

Typical Dose	200–500 µg per injection
Starting Dose	~250–300 µg once daily (beginners)
Route	Subcutaneous injection (subQ)
Frequency	Once or twice daily
Cycle Length	2–4 weeks typical; up to 6 weeks
Half-life	~30 minutes (short)

1

Gather Supplies

BPC-157 vial, bacteriostatic water, insulin syringes, alcohol swabs

2

Reconstitute

Add 2 mL bac water to 5 mg vial = 2.5 mg/mL. Swirl gently, don’t shake

3

Calculate Dose

250 µg = 0.1 mL (10 units) at 2.5 mg/mL concentration

4

Inject SubQ

Clean site with alcohol; inject into belly fat or near injury at 45° angle

5

Store Solution

Refrigerate at 2–8°C; use within 4–6 weeks

6

Rotate Sites

Alternate injection sites daily to avoid irritation

⚖️

BPC-157 vs TB-500

Both peptides accelerate healing but work through different mechanisms. They are often used together for complementary effects.

BPC-157

Gastric protein fragment (15 aa) 🫁 Gut + 🦴 Tendon Specialist

Cytoprotective + anti-inflammatory. Promotes angiogenesis, nitric oxide, growth factors. Short half-life (~30 min) → daily dosing. Best for gut healing, tendon/ligament repair, localized injuries.

TB-500

Thymus peptide (43 aa / fragments) 💪 Wound + 🫀 Cardiac Specialist

Cell migration + wound healing. Strong angiogenesis, collagen deposition. Longer half-life → less frequent dosing (1-2x/week). Best for skin wounds, muscle tears, cardiac repair.

💡

Synergy: BPC-157 + TB-500 is a common combination — BPC handles inflammation and protection while TB-500 drives cell migration and regeneration. Neither is FDA-approved; both are banned in sports.

❓

FAQ

What is BPC-157? A synthetic 15-amino acid peptide derived from human gastric juice, known for accelerating tissue healing, reducing inflammation, and protecting multiple organ systems. Is BPC-157 FDA approved? No. BPC-157 is not approved for any medical indication. It’s sold as a research chemical and is banned in competitive sports by WADA. How is it administered? Most commonly via subcutaneous injection (belly fat or near injury). It can also be taken orally (stable in stomach acid) but injection is more reliable for systemic effects. What are the side effects? Animal studies show no significant toxicity even at high doses. Anecdotal reports include mild headaches or injection site reactions. Long-term human effects are unknown. Does it cause cancer? No study has shown BPC-157 causing cancer. However, because it promotes angiogenesis, those with active malignancies should avoid it. It tested negative for mutagenicity. How long until results? Many report noticeable improvements (pain reduction, mobility) within 1–2 weeks. Full healing benefits typically require 2–4 weeks of consistent use. ✅

Bottom line: BPC-157 is a promising research peptide with remarkable healing properties across tendons, muscles, bones, and gut in animal studies. Its multi-modal mechanism (angiogenesis + anti-inflammation + growth factors) explains its broad benefits. However, it remains experimental with no FDA approval — use cautiously and for research purposes only.